Hellow guys, Welcome to my website, and you are watching Identification of Novel Protein Biomarkers in the Era of Precision Medicine Oncology. and this vIdeo is uploaded by Labroots at 2022-03-10T14:03:51-08:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | Identification of Novel Protein Biomarkers in the Era of Precision Medicine Oncology |
| Video Uploader | Video From Labroots |
| Upload Date | This Video Uploaded At 10-03-2022 22:03:51 |
| Video Discription | Presented By: Hilal Arnouk, MD, PhD Speaker Biography: Hilal Arnouk, MD, PhD is an Associate Professor at the Department of Pathology at Midwestern University. Dr. Arnouk has received his education and post-doctorate training at Roswell Park Cancer Institute, the State University of New York at Buffalo, the Medical College of Georgia and the University of Alabama at Birmingham. He has directed research studies in academia and biotech industry settings. His major areas of expertise include Cancer Immunotherapy, Biomarker Discovery and Precision Medicine. Additionally, Dr. Arnouk tremendously enjoys being an educator for professional students in the medical and biomedical sciences. Webinar: Identification of Novel Protein Biomarkers in the Era of Precision Medicine Oncology Webinar Abstract: Cancer is a leading cause of morbidity and mortality in developed countries including the United States. Early detection of various cancers, before they spread and become incurable, has been the best weapon in the war on cancer that began with the signing of the National Cancer Act in 1971. The premise of Precision Medicine is the ability to customize personalized medical care to individual patients through the incorporation of molecular profiles and clinical characteristics in treatment determination utilizing molecular diagnostics, and targeted therapies. Proteins uniquely produced by tumors and their surrounding microenvironment constitute valuable biomarkers that aid in diagnosis of initial tumors, screening the population, monitoring of tumor progression, metastases, response to treatment and relapse (e.g., the prostate-specific antigen, PSA, is routinely used for screening and monitoring of prostate cancer). Moreover, some biomarkers can stratify patients into sub-groups that differ in their prognosis and response to different treatment options, which allows designing individual treatment plans. For instance, the human epidermal growth factor receptor 2 (Her2-neu) is overexpressed in about 20% of breast cancer patients and can be targeted by a monoclonal antibody called Herceptin in these patients, which enhances the overall survival when combined with chemotherapy. Earn PACE Credits: 1. Make sure you’re a registered member of LabRoots https://www.labroots.com/webinar/identification-novel-protein-biomarkers-era-precision-medicine-oncology 2. Watch the webinar on YouTube or on the LabRoots Website https://www.labroots.com/ms/webinar/identification-novel-protein-biomarkers-era-precision-medicine-oncology 3. Click Here to get your PACE credits (Expiration date – February 23, 2024): https://www.labroots.com/credit/pace-credits/6957/third-party LabRoots on Social: Facebook: https://www.facebook.com/LabRootsInc Twitter: https://twitter.com/LabRoots LinkedIn: https://www.linkedin.com/company/labroots Instagram: https://www.instagram.com/labrootsinc Pinterest: https://www.pinterest.com/labroots/ SnapChat: labroots_inc |
| Category | Science & Technology |
| Tags | Science & Technology Download MP4 | Science & Technology Download MP3 | Science & Technology Download MP4 360p | Science & Technology Download MP4 480p | Science & Technology Download MP4 720p | Science & Technology Download MP4 1080p |
